Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danforth P Miller

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Molecular Pharmaceutics|August 4, 2015
Advances in Respiratory and Nasal Drug DeliveryDavid Lechuga-Ballesteros, Danforth P Miller
Journal of Pharmaceutical Sciences|August 22, 2015
Formulation Design of Dry Powders for InhalationJeffry G Weers, Danforth P Miller
Pharmaceutical Research|September 7, 2006
Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobilityDanforth P Miller, David Lechuga-Ballesteros
Pharmaceutical Research|March 15, 2003
Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solidsDavid Lechuga-Ballesteros, Aziz Bakri, Danforth P Miller
Journal of Pharmaceutical Sciences|April 20, 2026
Reimagining Carrier-Based Formulations for Inhalation: Respirable AgglomeratesJeffry G Weers, Thomas E Tarara, Danforth P Miller
Pharmaceutics|November 27, 2021
Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier FormulationsDanforth P Miller, Thomas E Tarara, Jeffry G Weers
Pharmaceutics|September 28, 2021
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder InhalerYoen-Ju Son, Danforth P Miller, Jeffry G Weers
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 8, 2026
Design of Dry Powder Inhalers: 1. Does Size Matter?Jeffry G Weers, Thomas E Tarara, Danforth P Miller
AAPS Pharmscitech|February 9, 2019
Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug ParticlesJeffry G Weers, Danforth P Miller, Thomas E Tarara
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 8, 2026
Design of Dry Powder Inhalers: 2. The Impact of Suboptimal Peak Inspiratory Flow Rates on Bronchodilation in Patients with Obstructive Lung DiseasesJeffry G Weers, Thomas E Tarara, Danforth P Miller
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Molecular Pharmaceutics|August 4, 2015
Advances in Respiratory and Nasal Drug DeliveryDavid Lechuga-Ballesteros, Danforth P Miller
Journal of Pharmaceutical Sciences|August 22, 2015
Formulation Design of Dry Powders for InhalationJeffry G Weers, Danforth P Miller
Pharmaceutical Research|September 7, 2006
Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobilityDanforth P Miller, David Lechuga-Ballesteros
Pharmaceutical Research|March 15, 2003
Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solidsDavid Lechuga-Ballesteros, Aziz Bakri, Danforth P Miller
Journal of Pharmaceutical Sciences|April 20, 2026
Reimagining Carrier-Based Formulations for Inhalation: Respirable AgglomeratesJeffry G Weers, Thomas E Tarara, Danforth P Miller
Pharmaceutics|November 27, 2021
Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier FormulationsDanforth P Miller, Thomas E Tarara, Jeffry G Weers
Pharmaceutics|September 28, 2021
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder InhalerYoen-Ju Son, Danforth P Miller, Jeffry G Weers
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 8, 2026
Design of Dry Powder Inhalers: 1. Does Size Matter?Jeffry G Weers, Thomas E Tarara, Danforth P Miller
AAPS Pharmscitech|February 9, 2019
Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug ParticlesJeffry G Weers, Danforth P Miller, Thomas E Tarara
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 8, 2026
Design of Dry Powder Inhalers: 2. The Impact of Suboptimal Peak Inspiratory Flow Rates on Bronchodilation in Patients with Obstructive Lung DiseasesJeffry G Weers, Thomas E Tarara, Danforth P Miller
Pageof 3